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Abstract
Objective
Invariant NKT (iNKT) cells play a role in regulating the function of autoreactive B cells before their entry into germinal 
centres. Absence and/or reduction of iNKT cells have been demonstrated in patients with systemic lupus erythematosus 
(SLE) together with an increase of autoreactive B cell activity. Primary Sjögren’s syndrome (pSS) is a systemic autoimmune 
disease in which lymphocyte infiltration and organisation in lymphoid structures of inflamed salivary glands occurs. 
The aim of the study was to investigate the percentage and function of iNKT in the salivary glands and peripheral blood 
of patients with pSS. 
Methods
Minor salivary gland biopsies were obtained from patients with pSS and with non-specific chronic sialoadenitis (nSS). 
Flow cytometry analysis of CD1d/α-GalactosylCeramide (α-GalCer) tetramer positive cells, producing IFN-γ and IL-17, 
and quantitative gene expression analysis by TaqMan real-time PCR for Vα24 were performed on salivary glands biopsies 
and peripheral blood samples obtained from patients and controls. Flow cytometry and immunofluorescence analysis for 
autoreactive B lymphocytes and ELISA for anti-SSA antibodies (Ab) detection were also performed. 
Results
An increase of iNKT was detected ex vivo in peripheral blood of pSS patients; after α-GalCer stimulation this subset 
produce IL-17 and IFN-iNKT were undetectable in the salivary glands of pSS patients and anti-SSA specific B cells were 
found in target tissue. Invariant NKT cells were able to inhibit autoantibody production by B cells obtained from salivary 
glands of pSS. 
Conclusion
Impaired iNKT migration to inflamed sites might induce the activation of autoreactive B cells specific for SSA-antigen in 
salivary glands of pSS patients. 
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Introduction
Primary Sjögren’s syndrome (pSS) is 
an autoimmune epithelitis character-
ised by chronic lymphocyte infiltra-
tion, organisation in lymphoid struc-
tures and auto-Ab production, leading 
to architectural destruction of the exo-
crine glands and resulting in the clas-
sical clinical signs and symptoms of 
mouth and eye dryness (1). The patho-
genesis of pSS seems to be multifacto-
rial and both innate and adaptive im-
munity play an important role leading 
to the organisation of ectopic lymphoid 
structures responsible of local B cell 
expansion and auto-antibody (autoAb) 
production (2). Many studies have un-
derlined the involvement of autoreac-
tive B lymphocytes in the pathogenesis 
of autoimmune disorders and demon-
strated that B cell activation increases 
in the absence or reduction of a cell 
subset that bridges innate and adap-
tive immunity, named natural killer T 
(NKT) cells (3, 4).
These lymphocytes are mainly charac-
terised by the expression of a unique 
(invariant) T cell receptor (TCR), 
Vα24Jα18Vβ11, capable of recognis-
ing glycolipids such as alpha-galac-
tosylceramide (α-GalCer), associated 
with the non-polymorphic CD1d mol-
ecule (5, 6). Upon α-GalCer/CD1d 
recognition, iNKT cells expand and 
produce large amounts of cytokines 
and chemokines both in vitro and in 
vivo (7, 8). Invariant NKT cells in-
clude CD8+, CD4+ and double negative 
CD4-/CD8- subsets all producing dif-
ferent cytokines, thus potentially play-
ing both protective and harmful roles 
in the progression of autoimmune dis-
eases (3, 4, 9). 
Activated iNKT cells have been report-
ed to enhance Ab responses against T-
dependent and T-independent antigens 
of pathogens (10) and to inhibit auto-
Ab-producing B cells, playing a sup-
portive and regulatory role on B cell 
functions. Invariant NKT cells appear 
in fact to inhibit autoAb production in 
a contact and CD1d-dependent man-
ner (11) and to regulate the function of 
autoreactive B cells before their entry 
into germinal centres (12). 
According to our knowledge, no spe-
cific evidence of the role of iNKT in 
pSS has been described. The aim of 
this study was to investigate the fre-
quency and function of iNKT cells in 
the salivary glands and in the periph-
eral blood of patients with pSS.
In this study we demonstrate that: 
1. iNKT cells were undetectable in the 
salivary glands of pSS patients, but are 
significantly expanded in the periph-
eral blood ex vivo and produced IL-17 
and IFN-γ after α-GalCer stimulation; 
2. iNKT cells from pSS patients ex-
press at low levels the chemokines 
receptors CXCR3, CCR6 and CCR5 
compared to iNKT from nSS subjects; 
3. a significant increase of autoreac-
tive B lymphocytes specific for SSA 
antigen occur in the inflamed salivary 
glands; 
4. activated iNKT cells in vitro inhibit 
anti-SSA Ab production by B cells ob-
tained from pSS. These results seem to 
suggest that iNKT absence in salivary 
glands may results in B cells activation 
and anti-SSA production.
Material and methods
Patients
For this study, twenty patients meet-
ing the American-European Consen-
sus Group criteria for pSS (20) were 
enrolled. Sixteen patients classified as 
having non-specific chronic siaload-
enitis (nSS) showing various degrees 
of mononuclear cell infiltration in the 
absence of focal organisation (these pa-
tients do not fulfill the American-Euro-
pean Consensus Group criteria for SS) 
were also included as a control group. 
All patients and controls underwent to 
minor salivary gland biopsy for histo-
logical diagnosis and peripheral blood 
were also collected at the time of enrol-
ment. The presence of other underlying 
autoimmune diseases or hepatitis C 
virus infection was carefully excluded. 
All pSS patients selected were positive 
for antinuclear antibodies, anti-SSA/
Ro, anti-SSB/La. Patients and controls 
also underwent serological evaluation 
for rheumatoid factor, levels of C-reac-
tive protein and erythrocyte sedimenta-
tion rate. Unstimulated whole sialom-
etry and the Schirmer Test were also 
performed. The baseline characteristics 
of patients and controls are shown in 
Table I.
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Flow cytometric analysis of iNKT 
in salivary gland mononuclear cells 
(SGMCs) and peripheral blood 
mononuclear cells (PBMCs) after 
αGalCer stimulation
Peripheral blood from pSS patients and 
control subjects were collected in hep-
arinised tubes. PBMCs were obtained 
after centrifugation on Ficoll-Hypaque 
(Pharmacia, Uppsala, Sweden). 
Salivary glands were digested as previ-
ously described (14). The medium used 
throughout was RPMI 1640 (Invitrogen 
Life Technologies) supplemented with 
5% heat-inactivated pooled human 
AB+ serum, 2 mM l-glutamine, 20 mM 
HEPES, 100 U/ml penicillin, 100 μg/
ml streptomycin, 5 × 10−5 M 2-ME. The 
cells were counted using Trypan Blue 
dye exclusion. The lymphocytes were 
cultured at 5 x 105/well in u-bottomed 
96 well plates (Nunc, Copenhagen 
Denmark).
PBMCs or SGMCs were incubated for 
5 days with (20 ng/ml) at 37°C 5% CO2. 
After incubation, cells were washed in 
complete medium and incubated with 
PE-labelled CD1d/αGal-Cer tetramers 
or PE-labelled CD1d-vehicle (Proim-
mune, Oxford, UK), washed, and ana-
lysed by flow cytometry on a FACSCal-
ibur using the CellQuest Pro software. 
Cells were also stained with FITC-la-
belled- anti- CXCR3, CCR6 and CCR5 
mAb (Beckton Dickinson, US). To as-
sess the cytokine content of tetramer+ 
iNKT cells, cells were fixed and per-
meabilised (Cytofix/Cytoper, Beckton 
Dickinson, US) and then stained with 
allophycocyanin-labelled anti-IFN-γ 
mAb (Beckton Dickinson, US) and 
PerCP-labelled anti-IL-17 mAb (Beck-
ton Dickinson, US) in incubation buffer 
(PBS containing 1% FCS and 0.1% 
sodium azide) for 30 min at 4°C. Cells 
were then washed twice in PBS with 1% 
FCS and analysed by flow cytometry. 
Viable lymphocytes were gated by for-
ward and side scatter, and analysis was 
performed on 100,000 acquired events 
for each sample. Mean of percentages 
obtained from patients and controls was 
statistically compared.
RT-PCR for iNKT receptor Vα24-Jα18
RNA was extracted from PBMCs and 
SGMCs isolated from pSS patients 
and nSS, before and after 5 days of 
in vitro treatment with α-Gal-Cer, us-
ing the commercially available illustra 
RNAspin Mini Isolation Kit (GE Health-
care, Little Chalfont, Buckinghamshire, 
UK), according to manufacturer’s in-
structions. Total RNA was reverse tran-
scribed to cDNA using the High Capac-
ity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, CA, 
USA). Samples were stored at −20°C 
until use. For quantitative TaqMan RT-
PCR, master mix and TaqMan gene 
expression assays for GAPDH (glycer-
aldehyde 3-phosphate dehydrogenase, 
Hs99999905_m1) control and iNKT 
receptor Vα24-Jα18 (Forward primer: 
5’-CCTCCCAGCTCAGCGATTC-3’; 
Reverse primer: 5’-TATAGCCTCCC-
CAGGGTTGA-3’; Probe: FAM-5’-C-
CTCCTACATCTGTGTGGTGAGC-
GACA-3’-TAMTph), were obtained 
from Applied Biosystems. Samples 
were run in duplicate using the Step-
One Real-Time PCR system (Applied 
Biosystems, Foster City, CA, USA). 
Relative changes in gene expression 
between paired patients before and after 
treatment, were determined using the 
ΔΔCt method. Levels of the target tran-
script were normalised to a GAPDH en-
dogenous control, constantly expressed 
in both groups (ΔCt). For ΔΔCt values, 
additional subtractions were performed 
between untreated and treated samples 
ΔCt values. Final values were expressed 
as fold of induction (FOI).
Detection of iNKT and autoreactive 
B lymphocytes by immunofluorescence
Salivary gland and tonsil (obtained 
from healthy controls) tissue samples 
were immediately fixed with 4% for-
maldehyde and embedded in paraffin. 
Staining was performed on 5-μm-thick 
paraffin-embedded sections as previ-
ously described (14). After dewaxing 
and dehydration, sections were stained 
with TCR-Vα24 antibody (Immuno-
tech SA, Marseilles, France). In order 
to study the general SSA-specific B 
cell pattern in the SG, double-staining 
experiments were carried out with 
CD19 in combination with SSA-Ag as 
described by Aqrawi et al. (15). Three 
sections for each sample were analysed 
by two different scientists or technician 
to avoid causalities of showed results.
Briefly, tissues were blocked with nor-
mal bovine serum and then incubated 
with SSA antigen (SSA-Ag) (20 μg/
ml) and stained with the primary anti-
body against SSA (rabbit anti-human 
SSA at a concentration of 1:100) and 
anti-CD19 (mouse anti-human CD19 
at a concentration of 1:100). Purified 
rabbit IgG control antibody was used 
instead of the primary antibody as 
a control. The secondary antibodies 
(goat anti-rabbit Ig, rabbit anti-mouse 
Ig), were added and incubated for 30 
min. Nuclei were counter stained with 
Toto3. The images were acquired with 
confocal microscope (Nikon).
Co-culture of B cells and iNKT  
PBMCs obtained from 5 patients were 
magnetically separated for Vα24-Jα18 
(anti-human Vα24-Jα18 -PE eBiosci-
ence, San Diego, CA), using anti PE-
microbeads (Miltenyi Biotec, Germany) 
to isolate iNKT. The negative cellular 
fraction was next enriched for CD19+ 
cells (Beckton Dickinson, US) using 
anti PE-microbeads (Miltenyi Biotec, 
Germany) and stimulated with SSA 
antigen. Next, the B lymphocytes were 
cultured alone or with activated iNKT 
(as indicated above) (iNKT:B cells ra-
tio 1:1 and 1:10) in RPMI medium sup-
plemented with 10% FCS in U-bottom 
96-well plates and incubated at 37°C, 
5% CO2 for 48 hours. After incubation, 
supernatants were collected to test anti-
SSA production by ELISA.
Anti-SSA ELISA
A sandwich ELISA system was devel-
oped using the anti-SSA mAbs as the 
capturing Ab. The ELISA kit was a kind 
gift by Dr. Lakshmanan Suresh  (Immco 
Diagnostics, Buffalo, NY). Superna-
tants derived from co-culture of iNKT 
and B lymphocytes were collected and 
stored at −80°C. All samples were ti-
trated two-fold in the same solution and 
assayed in triplicate on the ELISA plate. 
The ELISA test was performed accord-
ing to manufacturer instructions. The 
ELISA system could detect anti-SSA 
with a detection limit around 25 pg/ml.
Statistics
Statistical analysis of quantitative 
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variables was performed using the 
Mann-Whitney rank-sum test. Pear-
son’s correlation analysis was utilised 
to quantify the expression associations 
between the genes of interest. Data are 
expressed as mean ± SEM. p-values 
<0.05 were considered significant.
Results
As shown in Figure 1a and c, the mean 
of percentages of peripheral blood iNKT 
cells were significantly higher in pSS 
patients than in nSS before αGal-Cer 
culture (Fig. 1f). This difference was 
not statistically significant after in vitro 
stimulation with αGal-cer (Fig. 1b-c-
f). The mean expansion index (i.e.) of 
iNKT, calculated before and after in 
vitro culture, was higher in controls (i.e. 
43.7) than in patients (i.e. 23.1). These 
data were confirmed by RT-PCR, show-
ing an increase of almost three-fold of 
Vα24 gene expression (Fig. 1d) in pSS 
when compared to nSS. 
Then we tried to better characterise 
iNKT cells in pSS patients by analys-
ing their cytokine production. An in-
creased percentage of IL-17+ or IFN-γ+ 
iNKT was observed in pSS compared 
to nSS (Fig. 2a-b), after in vitro acti-
vation with αGal-Cer. The surface ex-
pression of CXCR3, CCR5 and CCR6 
was down regulated in iNKT of pSS 
when compared to nSS (Fig. 2c-e). 
Despite the expansion of iNKT in pe-
ripheral blood of pSS patients, these 
Fig. 1. iNKT percentage from PBMCs of pSS and nSS before and after αGalCer stimulation (the experiment was performed two times for each subject 
enrolled in the study). A-B: Mean percentages of iNKT cells before (A) and after (B) αGalCer  stimulation of PBMCs of patients and controls. C: Dot plot 
analysis of iNKTcells, stained with PE-labelled CD1d-αGalCer tetramer, before and after stimulation with αGalCer in one representative patient and con-
trol. D: Relative expression of Vα24 mRNA among PBMC of patients with pSS and nSS. Data are normalised for GAPDH and plotted as fold of induction. 
Results represent the mean±SEM. E Dot plot analysis showing isotype control. F: Dot plot displaying the coupled values of iNKT percentages before and 
after stimulation with αGalCer.
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cells were not detectable among 
SGMCs stimulated with αGal-Cer 
of both patients and controls by flow 
cytometry (Fig. 3a-b) and If assays 
(Fig. 3c). As a positive control for IF 
staining of iNKT, tonsil-derived cells 
were shown in Figure 3c. Vα24 gene 
expression was undetectable in biopsy 
and in salivary gland mononuclear 
cells cultured with αGal-cer of either 
pSS and nSS (data not shown). 
Considering the important role of iNKT 
cells in the control of B cell autoreac-
tivity and given the absence of iNKT 
in SGMCs we next evaluated the pres-
ence of auto-reactive B cells in the sali-
vary gland specimens of pSS and nSS 
patients. Interestingly we found SSA 
Fig. 2. Expression of IFN-γ and IL-17, and chemokines receptors among iNKT from peripheral blood of pSS patients and control after stimulations (the 
experiment was performed two times for each patient or control enrolled in the study). A-B Mean percentage of IFN-γ and IL-17 producing iNKT cells 
after αGalCer stimulation in patients and controls. C-E Mean percentages of CXCR3, CCR5 and CCR6 expressing  iNKT respectively. Results represent 
the mean±SEM.   
Fig. 3. iNKT are undetectable from isolated SGMS and in SG specimens. A-B: Dot plot analysis of iNKT 
stained with PE-labelled CD1d-αGalCer tetramers among SGMC of pSS, nSS (A) and  tonsil-derived cells (B). 
C:  Immunofluorescence for iNKT in SG tissue of pSS and tonsil-derived cells. The experiments were performed 
twice for each subject enrolled in the study.
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antigen-specific autoreactive  CD19+ B 
cells in the SGMC of pSS patients only 
(Fig. 4a-b). The absences of iNKT 
in the salivary glands of pSS patients 
among infiltrating cells (Fig. 4c-f), 
could contribute to the lack of regu-
lation of autoreactive B cells. In this 
regard, we evaluated the production 
of anti-SSA autoAb by salivary gland 
derived B lymphocytes after co-cul-
ture with different ratios of αGal-Cer-
activated iNKT cells. Interestingly, we 
found a statistically significant reduc-
tion of anti-SSA auto-Ab when B cells 
from patients were co-cultured with 
iNKT cells from patients but not when 
the cells were obtained from controls 
(Fig. 4g). The number of iNKT in the 
cultures was directly related with the 
inhibitory function displayed by these 
cells on autoreactive B cells. 
Discussion
The presence of high percentages of 
autoreactive B cells and the contem-
porary absence of iNKT cells charac-
terised the salivary glands of patients 
with pSS, conversely, high percentages 
of iNKT cells were observed in the pe-
ripheral blood of pSS patients. iNKT 
cells obtained from peripheral blood, 
after in vitro stimulation with αGalCer, 
expressed both IFN-γ and IL-17 and 
displayed low levels of the chemokine 
receptors CXCR3, CCR6 and CCR5 
on the cell surface in pSS patients re-
spect to controls. These findings seem 
to suggest that despite an activate phe-
notype, iNKT from pSS patients may 
have a possible low capacity to migrate 
towards inflammatory sites in response 
to relevant inflammatory chemokines. 
Furthermore, circulating iNKT were 
able to inhibit autoantibody production 
when in vitro co-cultured with B lym-
Fig. 4. iNKT inhibit anti-SSA secretion from autoreactive B cells. A-B  Immunofluorescence for CD19 (green) and SSA-Ag (red) in SG tissue of pSS (A) 
and nSS (B); nuclei were contrasted with Toto3 iodide. The experiments were performed two times for each subject enrolled in the study. C-F Sequential 
slide stained with haematoxilin and eosin respectively in pSS and nSS. G Anti-SSA were detected by supernatants obtained from co-cultures of B lympho-
cytes derived from salivary glands of pSS and nSS patients with iNKT derived from patients and controls at different ratios. Experiments were repeated three 
times. Data are reported as antiSSA (pg/ml) detected. 
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phocytes obtained from the salivary 
glands of pSS patients. 
Moreover iNKT, cultured with 
αGalCer, inhibit autoreactive B cells in 
a contact- and CD1d-dependent manner 
but are also able to activate non auto-
reactive B cells and/or activate auto-
reactive B cells via cytokines (11, 12). 
Low percentage of iNKT cells has been 
demonstrated in other autoimmune dis-
eases such as systemic lupus erythema-
tosus (SLE) and correlated with disease 
activity, suggesting a role in the control 
of autoreactive responses and disease 
pathogenesis (4, 9, 16, 17). In contrast 
with these observations and our present 
study, iNKT cell activation has been 
observed in the salivary gland of pa-
tients with pSS by Awada et al. (18). In 
their study, however, iNKT cells were 
identified as CD3+ CD16+ CD56+ cells, 
clearly not sufficient to identify iNKT 
cells (18). Conversely, in our study the 
glycolipid αGal-Cer was used to spe-
cifically stimulate iNKT cells (10, 19) 
and extremely specific probe capable 
to bind selectively the invariant TCR 
of NKT cells (the CD1d/ αGalCer te-
tramer) was used to proper identify 
these cells. 
The immune system is able to seques-
trate autoreactive B lymphocytes in the 
MZ and to organise these cells in ec-
topic GC-like structures as aggregates 
(20, 21). In this regard, the absence of 
iNKT cells in the salivary gland tissue 
might be responsible, at least in part, 
for the lack of control of B lymphocyte 
activation in situ, potentially leading 
to autoreactive B cells organisation in 
structures similar to germinal centre 
(GC). This capability of iNKTs to sup-
press autoAb production, without caus-
ing global suppression of B cells, may 
have important implications for the de-
velopment of iNKT-based therapy for 
autoimmune diseases.
More studies are clearly required to bet-
ter characterise the exact role of iNKT 
in pSS, including their complete pro-
file of cytokine/chemokine production, 
their migratory pattern and the mecha-
nisms underlying their regulatory ac-
tivities to design possible future iNKT 
cell-based immunotherapeutic strate-
gies. Nevertheless, our results may sug-
gest that in pSS expanded and activated 
circulating iNKT cells could be detect-
ed as a marker of the disease activity. 
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